Effectiveness of Cranberry Ingestion on Bacterial Adhesion: An Adjunct Study
1 other identifier
interventional
51
1 country
1
Brief Summary
This study is to help determine if drinking cranberry juice can decrease risk for asymptomatic bacteriuria (ASB). ASB occurs when there are bacteria in the urine without any symptoms. It will also see if there is a difference in this effect between pregnant and non-pregnant women.This research project is also designed to see what happens to bacterial binding to the lining of the bladder after drinking cranberry juice when special problems occur with pregnancy such as diabetes (a sugar metabolism problem) or ASB is already occurring.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2006
CompletedFirst Submitted
Initial submission to the registry
July 24, 2007
CompletedFirst Posted
Study publicly available on registry
July 25, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2008
CompletedResults Posted
Study results publicly available
June 8, 2010
CompletedDecember 18, 2017
November 1, 2017
1.5 years
July 24, 2007
December 3, 2009
November 17, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Antimicrobial Activity of Urine From Pregnant Subjects Following Cranberry Juice Cocktail (CJC)
The primary outcome measure was the measurement of bacteriuria in study subject urine, defined as having a urine culture with 100,000 or more of a single uropathogen (measured as cfu per ml).
7 months, from enrollment at 3 months of pregnancy to delivery
Study Arms (3)
Cranberry 2xday
ACTIVE COMPARATORCranberry juice (C) two times daily, a.m. and p.m.
Cranberry + Placebo
ACTIVE COMPARATORDe-Activated Cranberry juice in the am, then placebo (P) in the pm
Placebo 2xday
PLACEBO COMPARATORPlacebo in the form of juice two times daily in the a.m. and p.m.
Interventions
Low-calorie, Low-carbohydrate content 8 oz dose of Cranberry juice
De-Activated Cranberry juice in the am, then placebo (P) in the pm
Eligibility Criteria
You may qualify if:
- Intrauterine pregnancy
- Documented fetal viability (either by fetal heart tones present by Doppler auscultation, or by ultrasonic visualization of cardiac motion
- Estimated gestational age by last menstrual period and/or by ultrasonographic fetal measurements of 16 weeks or less
You may not qualify if:
- Suspected non-viable or ectopic gestation
- Patient desires pregnancy termination
- Significant underlying medical complication, such as chronic hypertension, insulin-requiring diabetes, chronic renal failure, cardiac disease, sickle cell disease, etc.
- Maternal age less than 18 years
- Patient is currently on or has received within the two weeks prior to enrollment antimicrobial therapy for reasons other than urinary tract infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, Irvine Medical Center
Orange, California, 92868, United States
Limitations and Caveats
Our study methodology could have been improved with a series of timed urine collections such as collections at pre-treatment, 2, 4 and 6 hours after ingestion of the cranberry juice cocktail and placebo to determine time of maximal effect.
Results Point of Contact
- Title
- Deborah A. Wing, MD
- Organization
- University of California Irvine Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Deborah A Wing, MD
University of California, Irvine
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Division of Maternal-Fetal Medicine, Obstetrics & Gynecology, University of California, Irvine School of Medicine
Study Record Dates
First Submitted
July 24, 2007
First Posted
July 25, 2007
Study Start
August 1, 2006
Primary Completion
February 1, 2008
Study Completion
February 1, 2008
Last Updated
December 18, 2017
Results First Posted
June 8, 2010
Record last verified: 2017-11
Data Sharing
- IPD Sharing
- Will not share